Abstract
Dermatologic TherapyVolume 35, Issue 7 e15511 LETTER Dexamethasone or prednisone: Which one should be the corticosteroid of choice in patients with pemphigus vulgaris? Parvaneh Hatami, Corresponding Author Parvaneh Hatami p_hatami2001@yahoo.com orcid.org/0000-0002-3531-2907 Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran Correspondence Parvaneh Hatami and Zeinab Aryanian, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran. Email: p_hatami2001@yahoo.com and z_aryanian@yahoo.comSearch for more papers by this authorKamran Balighi, Kamran Balighi Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, IranSearch for more papers by this authorNessa Aghazadeh Mohandesi, Nessa Aghazadeh Mohandesi Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USASearch for more papers by this authorHamed Nicknam Asl, Hamed Nicknam Asl Department of Dentistry, Rafsanjan University of Medical Sciences (RUMS), Rafsanjan, IranSearch for more papers by this authorZeinab Aryanian, Corresponding Author Zeinab Aryanian z_aryanian@yahoo.com Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran Department of Dermatology, Babol University of Medical Sciences, Babol, Iran Correspondence Parvaneh Hatami and Zeinab Aryanian, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran. Email: p_hatami2001@yahoo.com and z_aryanian@yahoo.comSearch for more papers by this author Parvaneh Hatami, Corresponding Author Parvaneh Hatami p_hatami2001@yahoo.com orcid.org/0000-0002-3531-2907 Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran Correspondence Parvaneh Hatami and Zeinab Aryanian, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran. Email: p_hatami2001@yahoo.com and z_aryanian@yahoo.comSearch for more papers by this authorKamran Balighi, Kamran Balighi Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, IranSearch for more papers by this authorNessa Aghazadeh Mohandesi, Nessa Aghazadeh Mohandesi Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USASearch for more papers by this authorHamed Nicknam Asl, Hamed Nicknam Asl Department of Dentistry, Rafsanjan University of Medical Sciences (RUMS), Rafsanjan, IranSearch for more papers by this authorZeinab Aryanian, Corresponding Author Zeinab Aryanian z_aryanian@yahoo.com Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran Department of Dermatology, Babol University of Medical Sciences, Babol, Iran Correspondence Parvaneh Hatami and Zeinab Aryanian, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran. Email: p_hatami2001@yahoo.com and z_aryanian@yahoo.comSearch for more papers by this author First published: 13 April 2022 https://doi.org/10.1111/dth.15511Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume35, Issue7July 2022e15511 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
